$293,554.69 ownership Payment -- Roche/Genentech to Dr. Rachel Parker
This page provides a detailed analysis of a $293,554.69 ownership payment from Roche/Genentech to Dr. Rachel Parker. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $293,554.69 |
| Payment Type | ownership |
| Payment Nature | Ownership or Investment Interest |
| Pharmaceutical Company | Roche/Genentech |
| Physician | Dr. Rachel Parker |
| NPI Number | 1886433057 |
| Physician Specialty | Neurology |
| Location | Camden, NJ |
| Date of Payment | 2024-12-20 |
| Related Drug/Device | Skyrizi |
Understanding ownership Payments
Ownership and investment interest payments represent dividends, returns, or other financial benefits from physician ownership stakes in pharmaceutical or medical device companies. These relationships represent the most direct form of financial interest and are subject to the strictest reporting requirements under the Sunshine Act.
Related Reports
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.